Skip to content

Clinical trials

Completed Myeloproliferative Disorders trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Status: Completed Country / region: Australia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20081
20091
20111
20121
20131
20141
20151
20191
20201

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group3
Incyte Corporation2
Novartis Pharmaceuticals2
Celgene1
S*BIO1
Sierra Oncology LLC - a GSK company1
Takeda1
The Canadian Blood and Marrow Transplant Group1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders12
Primary Myelofibrosis7
Bone Marrow Diseases4
Hematologic Diseases4
Anemia, Refractory3
Anemia, Refractory, with Excess of Blasts3
Leukemia3
Leukemia, Myelomonocytic, Chronic3
Myelodysplastic Syndromes3
Polycythemia Vera3

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.